Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Syst... by Tashi, Tsewang, Hermine, Olivier, Castells, Mariana, Guilarte, Mar, Sabato, Vito, Maurer, Marcus, Panse, Jens, Alvarez-Twose, Ivan, Cabral, Renata, Bird, Robert, Barete, Stéphane, Bouillet, Laurence, Hermans, Maud, Van Daele, Paul, González-De-Olano, David, Griffiths, Elizabeth A., Jurcic, Joseph, Dybedal, Ingunn, Damaj, Gandhi Laurent, Schafhausen, Philippe, Elena, Chiara, Teh, Tse-Chieh, Vachhani, Pankit, Labe, Caroline, Venugopal, Saranya, He, Kevin, Muñoz-González, Javier, Lampson, Ben, Scherber, Robyn, Bose, Prithviraj, Grattan, Clive, Pongdee, Thanai, George, Tracy I., Livideanu, Cristina Bulai

Get full text